| Product Code: ETC7140888 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Estonia Preimplantation Genetic Screening (PGS) Technology Market Overview |
3.1 Estonia Country Macro Economic Indicators |
3.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market - Industry Life Cycle |
3.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market - Porter's Five Forces |
3.5 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Product and Services, 2021 & 2031F |
3.8 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.10 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Estonia Preimplantation Genetic Screening (PGS) Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about genetic disorders and the importance of genetic screening |
4.2.2 Rising demand for advanced technologies in the healthcare sector |
4.2.3 Growing prevalence of genetic diseases in Estonia |
4.3 Market Restraints |
4.3.1 High costs associated with preimplantation genetic screening technology |
4.3.2 Limited availability of skilled professionals in the field of genetic screening |
4.3.3 Stringent regulations and ethical concerns related to genetic screening practices |
5 Estonia Preimplantation Genetic Screening (PGS) Technology Market Trends |
6 Estonia Preimplantation Genetic Screening (PGS) Technology Market, By Types |
6.1 Estonia Preimplantation Genetic Screening (PGS) Technology Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Screening, 2021- 2031F |
6.1.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Diagnosis, 2021- 2031F |
6.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.2.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fluorescence in Situ Hybridization, 2021- 2031F |
6.2.5 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.2.6 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Single-Nucleotide Polymorphism, 2021- 2031F |
6.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market, By Product and Services |
6.3.1 Overview and Analysis |
6.3.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Reagents and Consumables, 2021- 2031F |
6.3.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Software and Services, 2021- 2031F |
6.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Maternity Centers, 2021- 2031F |
6.4.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fertility Clinics, 2021- 2031F |
6.4.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Hospitals, Diagnostic Labs, 2021- 2031F |
6.4.5 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Service Providers, 2021- 2031F |
6.4.6 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.7 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.5 Estonia Preimplantation Genetic Screening (PGS) Technology Market, By Test Type |
6.5.1 Overview and Analysis |
6.5.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Chromosomal Abnormalities, 2021- 2031F |
6.5.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By X-linked Diseases, Embryo Testing, 2021- 2031F |
6.5.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Aneuploidy Screening, 2021- 2031F |
6.5.5 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By HLA Typing, 2021- 2031F |
6.5.6 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Other, 2021- 2031F |
6.6 Estonia Preimplantation Genetic Screening (PGS) Technology Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Embryo HLA Typing for Stem Cell Therapy, 2021- 2031F |
6.6.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By IVF Prognosis, 2021- 2031F |
6.6.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Late Onset Genetic Disorders, 2021- 2031F |
6.6.5 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Inherited Genetic Disease, 2021- 2031F |
6.6.6 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Others, 2021- 2031F |
7 Estonia Preimplantation Genetic Screening (PGS) Technology Market Import-Export Trade Statistics |
7.1 Estonia Preimplantation Genetic Screening (PGS) Technology Market Export to Major Countries |
7.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Imports from Major Countries |
8 Estonia Preimplantation Genetic Screening (PGS) Technology Market Key Performance Indicators |
8.1 Average turnaround time for genetic screening results |
8.2 Percentage increase in the adoption of preimplantation genetic screening technology |
8.3 Number of research collaborations and partnerships in the genetic screening industry |
8.4 Patient satisfaction rates with the accuracy of genetic screening results |
8.5 Rate of successful pregnancies following the use of preimplantation genetic screening |
9 Estonia Preimplantation Genetic Screening (PGS) Technology Market - Opportunity Assessment |
9.1 Estonia Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Estonia Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Product and Services, 2021 & 2031F |
9.4 Estonia Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Estonia Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.6 Estonia Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Estonia Preimplantation Genetic Screening (PGS) Technology Market - Competitive Landscape |
10.1 Estonia Preimplantation Genetic Screening (PGS) Technology Market Revenue Share, By Companies, 2024 |
10.2 Estonia Preimplantation Genetic Screening (PGS) Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here